Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Open Label, Single Arm Study to Assess Efficacy, Safety, Bleeding Pattern and Pharmacokinetics of the Ultra Low Dose Levonorgestrel Intrauterine Contraceptive System (LCS) for a Maximum of 3 Years in Women 18 to 40 Years of Age

NCT00884260 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00884260
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00884260 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Open Label, Single Arm Study to Assess Efficacy, Safety, Bleeding Pattern and Pharmacokinetics of the Ultra Low Dose Levonorgestrel Intrauterine Contraceptive System (LCS) for a Maximum of 3 Years in Women 18 to 40 Years of Age
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2009
Completion date
June 30, 2013
Enrollment
918 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

contraception